Navigation Links
Diabetics Need to Guard Against Nail Fungus

Many people with diabetes have nail fungus, which can have a serious impact on their health and quality of life. The American Association of Diabetes Educators (AADE) says about a third of the estimated Americans who have diabetes develop onychomycosis, the most common type of nail fungus. Because of poor circulation in the extremities and a reduced ability to fight infection, people with diabetes are at greater risk for nail fungus.//
For people with diabetes, nail fungus may start out as an embarrassment. But if left untreated, nail fungus can progress to skin and bone infections or even tissue death, leading to a loss of mobility and independence. Symptoms of nail fungus include changes in the color, texture and thickness of the nail. The nail may be easily broken and the toenail may thicken and cause pressure, especially when shoes are worn. People with nail fungus may have trouble walking or wearing shoes. The infection can spread to other nails and other people.

Now that the warm weather is here, people with diabetes may be at greater risk of developing nail fungus. That's because they're more exposed to specific risk factors such as walking barefoot in swimming pools, communal showers and other areas potentially contaminated with nail fungus.

The AADE offers these tips on preventing nail fungus:
Don't wear tight-fitting shoes or the same pair of shoes every day.
Wear socks that absorb moisture.
Wash and dry feet daily.
Remove shoes and socks at every doctor visit so you feet can be examined.
Treatment for nail fungus may include oral or topical antifungal agents.

'"/>




Page: 1

Related medicine news :

1. Cinnamon May Help Diabetics
2. Heart disease threat starts early in life for Diabetics
3. Diabetics and their babies
4. Beta-Carotene May Aid Diabetics
5. Diabetics prone to periodontitis
6. Blood Vessel Surgery Safe for Diabetics
7. Marriage does good for Diabetics
8. Niacin Safe for Diabetics
9. Diabetics & Foot infections
10. Pancreas Transplant for Diabetics
11. Poor Preventive Measures Taken By Diabetics
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/23/2017)... CA (PRWEB) , ... February 23, 2017 , ... CALNOC, ... FACP, FACMPE, FACPE, will keynote their upcoming conference – Empowerment, Value and Collaboration – ... the chairman and CEO of the Virginia Mason Health System in Seattle since 2000. ...
(Date:2/23/2017)... ... February 23, 2017 , ... Curemark, LLC announced today that ... of CM-AT in children aged 3-8 with Autism, is now enrolling at three new ... children across the United States. , “There are currently no approved drugs that ...
(Date:2/23/2017)... ... ... Thomas Vas-Don suffered from severe injury due to an ... successfully recover. In “ Origin & Insertion Charts for Massage Therapists ” (published by ... massage, anatomy , trigger points and referral pain patterns . , In ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... ... and lobby of a new healthcare contact center in Georgia, PENETRON Specialty Products ... of the nation’s largest healthcare systems recently invested $51 million to purchase and ...
(Date:2/22/2017)... Raton, FL (PRWEB) , ... February 22, 2017 , ... ... primarily from deer antler velvet, announced its products are coming soon to Amazon.com, the ... Clint and Shelley Thomson as a means to develop an effective natural treatment for ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... February 23, 2017 Persistence ... the global market for intraoperative imaging, excerpts from ... at US$ 513.9 million. According to the report, ... on the grounds of increasing adoption of minimally-invasive ... of diagnostic imaging for neurosurgeries. The world,s leading ...
(Date:2/23/2017)... DUBLIN , Feb 23, 2017 Research ... Prosthetic Devices Market Analysis & Trends - Industry Forecast to 2025" ... ... to grow at a CAGR of around 9.2% over the next ... industry report analyzes the market estimates and forecasts for all the ...
(Date:2/23/2017)... , Feb. 23, 2017 MabVax ... oncology drug development company, announces that it has ... Administration (FDA) authorizing the initiation a Phase I ... for pancreatic cancer. MVT-1075 ( 177 Lu-CHX-A?-DTPA-HuMab5B1) is ... MabVax plans to initiate the phase I clinical ...
Breaking Medicine Technology: